One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25 years. Among older people with diabetes, 30-45% are affected by frailty (Frailty) The risk of frailty increases with increasing HbA1c. The incidence of atherosclerotic cardiovascular disease (ASCVD) doubles with age, with a prevalence of 38.5% for coronary heart disease (CHD), 13% for stroke and 12% for peripheral arterial disease (PAD) in people aged ≥70 years. In addition to their glucose-controlling effect, new antidiabetic drugs have organ-protective benefits and have brought about a paradigm shift in diabetology.
Autoren
- Dr. med. Young Hee Lee-Barkey
- PD Dr. rer. nat. Bernd Stratmann
- Prof. Dr. med. Susanne Reger-Tan
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Multiple sclerosis
Vitamin D as an adjuvant in multiple sclerosis: statistical success and clinical limitations
- From symptom to diagnosis
Abdominal pain – internal hernias
- Artificial intelligence for COPD
A new era of personalized treatment
- Multiple sclerosis
Spirulina as adjuvant therapy? Reduction of cytokines and inflammation
- IBD and SARS-CoV-2
Vulnerable at the mercy of others
- Case Report
53-year-old female patient with palmoplantar keratoderma
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Incontinence